Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Z-LLY-FMK | 133410-84-1 | 98.7% | 557.65 g/mol | C30H40FN3O6 | 5 MG
SDP

Catalog No. 5000222440
Encompass_Preferred

Z-LLY-FMK (Calpain Inhibitor IV) is a cell-permeable, irreversible peptide-based inhibitor of calpain proteases used in research to investigate apoptosis and parasite infection models. It is supplied as a solid powder with high reported purity and characterized chemical properties for laboratory use.

  • Irreversible inhibitor of calpain proteases, useful for apoptosis studies.
  • Cell-permeable peptide suitable for in vitro and in vivo research.
  • High purity (~98.7%) for reliable experimental results.
  • White to off-white solid with good solubility in common organic solvents.
  • Stability information provided for powder and solution storage.

Catalog No. 50-002-22440 Supplier Medchemexpress LLC Supplier No. HY1367505MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Z-LLY-FMK (Calpain Inhibitor IV) is a cell-permeable, irreversible peptide-based inhibitor of calpain proteases used in research to investigate apoptosis and parasite infection models. It is supplied as a solid powder with high reported purity and characterized chemical properties for laboratory use.

  • Irreversible inhibitor of calpain proteases, useful for apoptosis studies.
  • Cell-permeable peptide suitable for in vitro and in vivo research.
  • High purity (~98.7%) for reliable experimental results.
  • White to off-white solid with good solubility in common organic solvents.
  • Stability information provided for powder and solution storage.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.